Skip to main content

Web Exclusives

FDA Updates
February 1, 2019 - FDA Approvals, News & Updates
Yvette Florio Lane
Read More
Breast Cancer
5 mg Tamoxifen as Effective as 20 mg Daily in Early Localized Breast Cancer
Phoebe Starr
Read More
Immunotherapy, Renal-Cell Carcinoma
Avelumab plus Axitinib Combination Improves Outcomes in Advanced Renal-Cell Carcinoma
Wayne Kuznar
Read More
FDA Updates
Government Shutdown Impacts FDA Drug Approvals
Yvette Florio Lane
Read More
Colorectal Cancer, Immunotherapy
Nivolumab-Ipilimumab Combination Highly Active in Metastatic MSI-H or dMMR Colorectal Cancer
Read More
Targeted Intervention Reduces Opioid Use by Nearly 50% After Urologic Oncology Surgery
Read More
Supportive Care
Managing Bone Metastases Through a Multidisciplinary Approach
Meg Barbor, MPH
Read More
FDA Updates
Braftovi Plus Mektovi a New Combination for Unresectable or Metastatic Melanoma with BRAF Mutation
Read More
Cannabis for Symptom Management in Cancer: Do You Know What Your Patients Are Using?
Read More
Immunotherapy
Building on the Successes of Cancer Immunotherapy
Charles Bankhead
Read More
Page 27 of 43
Results 261 - 270 of 430